rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5924
|
pubmed:dateCreated |
1983-9-9
|
pubmed:databankReference |
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00718,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00719,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00720,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00721,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00722,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00723,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00724,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00725,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00726,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00727,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00728,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00729,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00730,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00731,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00732,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00733,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00734,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00735,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00736,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00737,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00738,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00739,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00740,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00741,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00742,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00743,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00744,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00745,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00746,
http://linkedlifedata.com/resource/pubmed/xref/GENBANK/K00747
|
pubmed:abstractText |
Light and heavy chain mRNAs of 15 anti-oxazolone antibodies were sequenced directly using synthetic primers. Hybridomas obtained 7 days after primary immunization show that they are of restricted heterogeneity. The majority expressed a single sequence with minor differences concentrated in the D region and joining boundaries D--JH and V kappa--J kappa.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0028-0836
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
304
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
320-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6877353-Animals,
pubmed-meshheading:6877353-Antibodies, Monoclonal,
pubmed-meshheading:6877353-Base Sequence,
pubmed-meshheading:6877353-Immunoglobulin G,
pubmed-meshheading:6877353-Immunoglobulin Idiotypes,
pubmed-meshheading:6877353-Mice,
pubmed-meshheading:6877353-Mice, Inbred BALB C,
pubmed-meshheading:6877353-Oxazoles,
pubmed-meshheading:6877353-Oxazolone,
pubmed-meshheading:6877353-RNA, Messenger
|
pubmed:articleTitle |
mRNA sequences define an unusually restricted IgG response to 2-phenyloxazolone and its early diversification.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|